Form 8-K · Current report
JPMorgan Chase 8-K, filed Oct 20, 2026
- Filed
- CIK
- 0000019617
- Accession no.
- 0001193125-26-426704
Summary
JPMorgan Chase closed public offerings of $7 billion in notes on October 20, 2026, comprising $350 million of floating rate notes due 2030, $2.9 billion of fixed-to-floating rate notes due 2030, and $3.75 billion of fixed-to-floating rate notes due 2037. Simpson Thacher & Bartlett LLP provided the legality opinion filed with the offering.
Key points
- The offerings were registered under the Securities Act of 1933 under a Form S-3 registration statement.
- The floating rate notes due 2030 total $350 million in aggregate principal amount.
- The fixed-to-floating rate notes due 2030 total $2.9 billion and those due 2037 total $3.75 billion.
- Simpson Thacher & Bartlett LLP's opinion on the legality of the notes was filed as Exhibit 5.1, with its consent as Exhibit 23.1.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 8.01Other Events
- 9.01Financial Statements and Exhibits
From the filing
Item 8.01. Other Events. On October 20, 2026, JPMorgan Chase & Co. closed public offerings of (i) $350,000,000 aggregate principal amount of Floating Rate Notes due 2030 (the “Floating Rate Notes”), (ii) $2,900,000,000 aggregate principal amount of Fixed-to-Floating Rate Notes due 2030 (the “2030 Fixed-to-Floating Rate Notes”) and (iii) $3,750,000,000 aggregate principal amount of Fixed-to-Floating Rate Notes due 2037 (together with the Floating Rate Notes and the 2030 Fixed-to-Floating Rate Notes, the “Notes”). The offerings of the Notes were registered under the Securities Act of 1933, as amended, pursuant to a registration statement on Form S-3 (File No. 333-285537), as amended. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.